Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab in Male Infertility
NCT02422108Phase 2Completed
- Start
- May 2015
- Primary completion
- Feb 2017
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of denosumab in male infertility. Started May 2015; status: completed.
02
Drugs
denosumab
03
Conditions
male infertility
Beyond the preview
Go deeper on NCT02422108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02422108.